CN Mobile Logo


The authors present a case of AL amyloidosis with rare GI involvement and an equally rare presenting symptom.

There is one way doctors can be more transparent to their patients about their relationships with pharmaceutical companies.

A program implemented in New York City successfully increased colorectal cancer screening rates and diminished racial and ethnic disparities in screening.

The ALK inhibitor alectinib was highly active and well-tolerated in patients with ALK-rearranged, crizotinib-refractory, advanced non–small-cell lung cancer.

The novel immunotherapy combination of epacadostat plus pembrolizumab shows promising clinical activity in advanced melanoma patients.

Today the FDA approved the PD-1 inhibitor nivolumab (Opdivo) as a single-agent frontline treatment for patients with BRAF wild-type advanced melanoma.

Puzzle out the cause of an unusual bruise on the ankle of a young boy in this slide show based on a true story.


Subscribe to Cancer Network RSS

By clicking Accept, you agree to become a member of the UBM Medica Community.